kneat.com (KSI) Stock Price, News & Analysis

Company Overview

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in various applications, including document management, analytical instrument validation, method validation, commissioning and qualification, drawing management, utility and facility validation, cold chain validation, electronic logbook management, process validation, computer system validation, and cleaning validation. The company also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.

Key Stats

• Today's Range: C$6.41 to C$6.53
• 50-Day Range: C$4.98 to C$6.45
• 52-Week Range: C$3.16 to C$6.53
• Volume: 128,055 shs
• Average Volume: 98,938 shs
• Market Capitalization: C$554.70 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: C$6.00
• Consensus Rating: Strong Buy

kneat.com Stock Analysis - MarketRank™

kneat.com scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

kneat.com has received a consensus rating of Strong Buy. The company's average rating score is 3.67, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

kneat.com has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of kneat.com is -40.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of kneat.com is -40.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

kneat.com has a PEG Ratio of 597.67. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

kneat.com has a P/B Ratio of 18.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for KSI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

kneat.com does not currently pay a dividend.

Dividend Growth

kneat.com does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for KSI.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

kneat.com has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for kneat.com this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added kneat.com to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, kneat.com insiders have not sold or bought any company stock.

Percentage Held by Insiders

25.96% of the stock of kneat.com is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 13.03% of the stock of kneat.com is held by institutions.

KSI Stock Analysis - Frequently Asked Questions

How have KSI shares performed this year?

kneat.com's stock was trading at C$5.86 on January 1st, 2025. Since then, KSI stock has increased by 10.1% and is now trading at C$6.45.
View the best growth stocks for 2025 here.

How were kneat.com's earnings last quarter?

kneat.com, inc. (TSE:KSI) released its quarterly earnings results on Wednesday, November, 6th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.05) by $0.06. kneat.com had a negative trailing twelve-month return on equity of 51.13% and a negative net margin of 31.19%.

How do I buy shares of kneat.com?

Shares of KSI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of kneat.com own?

Based on aggregate information from My MarketBeat watchlists, some other companies that kneat.com investors own include Arista Networks (ANET), PayPal (PYPL), NVIDIA (NVDA), MercadoLibre (MELI), Enterprise Products Partners (EPD), NextEra Energy Partners (NEP) and Enbridge (ENB).

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: TSE:KSI
• CUSIP: N/A
• CIK: N/A
• Web: www.kneat.com
• Phone: 353 6 120 3826
• Fax: N/A
• Employees: 293
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$6.00
• High Stock Price Target: C$6.00
• Low Stock Price Target: C$6.00
• Potential Upside/Downside: -6.4%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.67
• Research Coverage: 3 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.16)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 597.67
• Net Income: C$-12,680,000.00
• Net Margins: -31.19%
• Pretax Margin: N/A
• Return on Equity: -51.13%
• Return on Assets: -9.84%

Debt

• Debt-to-Equity Ratio: 95.14
• Current Ratio: 1.47
• Quick Ratio: 1.50

Sales & Book Value

• Annual Sales: C$40.66 million
• Price / Sales: 13.56
• Cash Flow: C$0.49 per share
• Price / Cash Flow: 13.18
• Book Value: C$0.35 per share
• Price / Book: 18.31

Miscellaneous

• Outstanding Shares: 86,000,000
• Free Float: N/A
• Market Cap: C$551.26 million
• Optionable: Not Optionable
• Beta: 1.08